We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$1.21B
AUM Growth
-$248M
Cap. Flow
-$400M
Cap. Flow %
-32.99%
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 13.03%
2 Technology 7.51%
3 Consumer Discretionary 5.23%
4 Financials 5.2%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLR
776
DELISTED
Kaleyra, Inc.
KLR
-61,353
Closed -$868K
ISEE
777
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-50,000
Closed -$255K
AKUS
778
DELISTED
Akouos Inc
AKUS
-40,000
Closed -$900K
EPZM
779
DELISTED
Epizyme, Inc
EPZM
-50,000
Closed -$803K
XLNX
780
CALL
DELISTED
Xilinx Inc
XLNX
-3,000
Closed -$295K
CCAC.U
781
DELISTED
CITIC Capital Acquisition Corp. Units, each consisting of one Class A ordinary share, $0.0001 par va
CCAC.U
-200,000
Closed -$2.01M
TREB.U
782
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
-293,500
Closed -$3.07M
KSU
783
DELISTED
Kansas City Southern
KSU
-1,838
Closed -$274K
KSU
784
PUT
DELISTED
Kansas City Southern
KSU
-3,500
Closed -$523K
XLRN
785
DELISTED
Acceleron Pharma
XLRN
-15,000
Closed -$1.43M
MXIM
786
CALL
DELISTED
Maxim Integrated Products
MXIM
-6,000
Closed -$364K
MXIM
787
PUT
DELISTED
Maxim Integrated Products
MXIM
-13,600
Closed -$824K
ALXN
788
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
-2,500
Closed -$281K
JWS.U
789
DELISTED
Jaws Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one red
JWS.U
-100,000
Closed -$1.05M
LGVW.U
790
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
-100,000
Closed -$1.01M
GHIVU
791
DELISTED
Gores Holdings IV, Inc. Unit
GHIVU
-100,000
Closed -$1.04M
IPOC.U
792
DELISTED
Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an
IPOC.U
-100,000
Closed -$1.2M
LOAK.U
793
DELISTED
Live Oak Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half
LOAK.U
-50,000
Closed -$503K
IPOB.U
794
DELISTED
Social Capital Hedosophia Holdings Corp. II Units, each consisting of one Class A ordinary share and
IPOB.U
-250,000
Closed -$3.14M
FEAC.U
795
DELISTED
Flying Eagle Acquisition Corp. Units, each consisting of one share of Class A common stock and one-f
FEAC.U
-200,000
Closed -$2.33M
FMCIW
796
DELISTED
Forum Merger II Corporation Warrant
FMCIW
-150,000
Closed -$747K
CCXX.U
797
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
-100,000
Closed -$1.13M
DLPH
798
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
-175,813
Closed -$2.5M
LM
799
DELISTED
Legg Mason, Inc.
LM
-5,798
Closed -$288K
TMUSR
800
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
-51,569
Closed -$9K

Similar funds

Maven Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.

  • Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
  • Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
  • Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
  • Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
  • Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
  • Maven Securities opened 297 new positions and closed 223 in Q3 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.

Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.